Skip to content
OpenCapital
Get started

Korro Bio, Inc. KRRO Q3 2025 earnings

Reported November 12, 2025 · Before market open

Revenue$1.1MBeat by $665.0K
EPS-$1.92Beat by $0.69
Revenue estimate$425.0K
EPS estimate-$2.61

Next report

Aug 11, 2026 (In 1 week)
Revenue estimate$214.3K
EPS estimate-$1.34

Versus estimates

Revenue

Q4 2025$1.3MBeat by $600.0K
Q3 2025$1.1MBeat by $665.0K
Q2 2025$1.5MBeat by $1.1MQ1 2025$2.6MBeat by $2.1MQ4 2024$2.3M

Diluted EPS

Q1 2026-$1.69Miss by $0.09Q4 2025-$5.32Miss by $3.39
Q3 2025-$1.92Beat by $0.69
Q2 2025-$2.74Miss by $0.20Q1 2025-$2.49Beat by $0.11Q4 2024-$2.26Beat by $0.07

Ask the moment Korro Bio, Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Korro Bio, Inc. report Q3 2025 earnings?
Korro Bio, Inc. (KRRO) reported Q3 2025 earnings on November 12, 2025 before market open.
What were Korro Bio, Inc.'s Q3 2025 revenue and EPS?
Korro Bio, Inc. reported revenue of $1.1M and eps of $-1.92 for Q3 2025.
Did Korro Bio, Inc. beat estimates in Q3 2025?
Revenue beat the consensus estimate of $425.0K by $665.0K. EPS beat the consensus estimate of $-2.61 by $0.69.
How did Korro Bio, Inc.'s Q3 2025 results compare year-over-year?
Compared to the same quarter a year prior, eps grew 15.0% from $-2.26.
Where can I find Korro Bio, Inc.'s Q3 2025 SEC filings?
You can read the 8-K earnings release (0001193125-25-277556) and the 10-Q periodic report (0001193125-25-277572) directly on SEC EDGAR. The filing index links above go to sec.gov.